Literature DB >> 18753641

Stroke prevention--insights from incoherence.

David M Kent, David E Thaler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753641     DOI: 10.1056/NEJMe0806806

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Antiplatelet agents for stroke prevention.

Authors:  Samuel Yip; Oscar Benavente
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

2.  Platelet function in stroke/transient ischemic attack patients treated with tocotrienol.

Authors:  Andrew Slivka; Cameron Rink; David Paoletto; Chandan K Sen
Journal:  FASEB J       Date:  2020-07-20       Impact factor: 5.191

Review 3.  Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.

Authors:  Cathie Lm Sudlow; Gillian Mason; James B Maurice; Catherine J Wedderburn; Graeme J Hankey
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

4.  Understanding the PRoFESS Study for Secondary Stroke Prevention.

Authors:  Michael J Schneck
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-06

5.  Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.

Authors:  Ludovic Trinquart; Adeline Abbé; Philippe Ravaud
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

6.  Antiplatelet Therapy After Noncardioembolic Stroke.

Authors:  Jacoba P Greving; Hans-Christoph Diener; Johannes B Reitsma; Philip M Bath; László Csiba; Werner Hacke; L Jaap Kappelle; Peter J Koudstaal; Didier Leys; Jean-Louis Mas; Ralph L Sacco; Ale Algra
Journal:  Stroke       Date:  2019-06-10       Impact factor: 7.914

7.  Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.

Authors:  Christine Benn Christiansen; Jannik Pallisgaard; Thomas Alexander Gerds; Jonas Bjerring Olesen; Mads Emil Jørgensen; Anna Karin Numé; Nicholas Carlson; Søren Lund Kristensen; Gunnar Gislason; Christian Torp-Pedersen
Journal:  BMC Neurol       Date:  2015-11-02       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.